79606-48-7

Usage

Uses

Used in Organic Synthesis:
N,N-diisopropyl-4-nitrobenzamide is utilized as a reagent in organic synthesis for the preparation of various chemical compounds. Its unique structure allows it to participate in a range of chemical reactions, facilitating the creation of new molecules with potential applications in different industries.
Used in Pharmaceutical Development:
In the pharmaceutical industry, N,N-diisopropyl-4-nitrobenzamide is employed as a precursor for the synthesis of various drugs. Its ability to be modified and incorporated into complex molecular structures makes it a valuable component in the development of new medications.
Used in Agrochemical Production:
N,N-diisopropyl-4-nitrobenzamide also serves as a precursor in the production of agrochemicals, which are essential for the agricultural sector. These chemicals can be used in the development of pesticides, herbicides, and other products that contribute to increased crop yields and protection against pests.
Safety Considerations:
Given its flammable nature and potential to cause irritation, proper handling and storage protocols are essential when working with N,N-diisopropyl-4-nitrobenzamide. This includes using personal protective equipment, such as gloves and safety goggles, and adhering to safety guidelines to minimize risks associated with its use.

InChI:InChI=1/C13H18N2O3/c1-9(2)14(10(3)4)13(16)11-5-7-12(8-6-11)15(17)18/h5-10H,1-4H3

Upstream product

• 122-04-3 4-nitro-benzoyl chloride 
• 108-18-9 diisopropylamine 
• 62-23-7 4-nitro-benzoic acid 

Downstream Products

• 79606-42-1 4-amino-N,N-diisopropylbenzamide 
• 1417547-05-7 N-(4-(diisopropylcarbamoyl)phenylcarbamoyl)-2,6-difluorobenzamide 
• 38681-76-4 N-isopropyl-4-nitrobenzamide 
• 144072-30-0 4-((tert-butoxycarbonyl)amino)benzaldehyde 
• 555-16-8 4-nitrobenzaldehdye 
• 1375931-20-6 2-bromo-N,N-diisopropyl-4-nitrobenzamide 

Relevant academic research and scientific papers

Design, synthesis, and insecticidal evaluation of new benzoylureas containing amide and sulfonate groups based on the sulfonylurea receptor protein binding site for diflubenzuron and glibenclamide

On the basis of the sulfonylurea receptor (SUR) protein binding site for diflubenzuron and glibenclamide, 15 new benzoylphenylureas containing amide and sulfonate groups were designed and synthesized. Their structures were characterized by 1H n

High-yielding, versatile, and practical [Rh(III)Cp*]-catalyzed ortho bromination and iodination of arenes

We report a uniquely high-yielding, general, and practical ortho bromination and iodination reaction of different classes of aromatic compounds. This reaction occurs by Rh(III)-catalyzed C-H bond activation methodology and is therefore the first example of the application of this cationic catalyst for C-Br and C-I bond formation.

Disubstituted lavendustin a analogs and pharmaceutical compositions comprising the analogs

Disubstituted lavendustin A analogs that are PTK inhibitors having antiproliferative activity are described. Preferred compounds of the present invention, without limitation, satisfy either Formula 1 or Formula 2. Currently preferred compounds ,based on in vivo biological activity, are 4'-adamantylbenzoate-1'-N-1,4-dihydroxybenzylamine and 4'-adamantylmethylbenzoate-1'-N-1,4-dihydroxybenzylamine. The present invention also provides pharmaceutical compositions comprising effective amounts of disubstituted lavendustin A analogs. Such compositions also may comprise other active ingredients, other materials conventionally used in the formulation of pharmaceutical composition, and mixtures thereof. The compounds and compositions of the present invention can be used for treating subjects to, for example, inhibit the proliferation of living cells in the treatment of proliferative diseases.

Antagonists of gonadotropin releasing hormone

There are disclosed compounds of formula (I) and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related and other conditions in both men and women.

ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE

There are disclosed compounds of formula (I) STR1 and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related and other conditions in both men and women.

ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE

There are disclosed compounds of formula (I) STR1 and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related and other conditions in both men and women.

ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE

There are disclosed compounds of formula (I) STR1 and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related and other conditions in both men and women.

ANTAGONISTS OF GONADOTROPIN RELEASING HORMONE

There are disclosed compounds of formula (I) STR1 and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related and other conditions in both men and women.

Novel 5α-reductase inhibitors. Synthesis and structure-activity studies of 5-substituted 1-methyl-2-pyridones and 1-methyl-2-piperidones

In search for nonsteroidal inhibitors of 5α-reductase for the treatment of benign prostatic hyperplasia (BPH) and possibly prostate cancer, substrate mimicks were synthesized comprising of a 1-methyl-2-pyridone (2, 4-16) or 1-methyl-2-piperidone (1, 3, 17